Cargando…

Gender-specific differences in young patients receiving implantable cardioverter-defibrillator therapy - a subgroup analysis of the german device registry

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillators (CRT-D) are well established therapies in heart failure. Therapeutic and technological advancements led to increasing numbers of youn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schlichting, A, Senges, J, Hochadel, M, Thomas, D, Voss, F, Straube, F, Bonaventura, K, Leschke, M, Zrenner, B, Becker, R, Willems, S, Hakmi, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	14.2 - Implantable Cardioverter-Defibrillator (ICD)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207642/ http://dx.doi.org/10.1093/europace/euad122.417

Ejemplares similares

Impact of gender on the utilization of cardiac implantable devices and outcome: results from the German DEVICE registry
por: Popescu, S S, et al.
Publicado: (2023)

Standard and extended electrocardiographic screening for the subcutaneous implantable cardioverter-defibrillator
por: Lewandowski, M, et al.
Publicado: (2023)

Perioperative and postoperative pain in patients undergoing subcutaneous implantable cardioverter-defibrillator placement
por: Bisignani, A, et al.
Publicado: (2023)

Ventricular tachycardia as presenting arrhythmia as a determinant of appropriate implantable cardioverter-defibrillator therapy in secondary prevention
por: Noordman, A B P, et al.
Publicado: (2023)

Amiodarone does not significantly affect the success rate of ventricular fibrillation induction tests performed during or after ICD implantation. Insights from the German DEVICE registry
por: Wiedmann, F, et al.
Publicado: (2023)

Clinical predictors of very low defibrillation threshold in the extravascular ICD
por: Murgatroyd, F, et al.
Publicado: (2023)

Intermuscular two-incision technique for implantation of the subcutaneous implantable defibrillator: 3-year follow-up
por: Migliore, F, et al.
Publicado: (2023)

Post-shock acute electrical parameters of left bundle branch area defibrillation (LBBAD) leads
por: Huybrechts, W, et al.
Publicado: (2023)

Defibrillation testing during S-ICD implantation: How relevant? Results from a multicenter study
por: Ben Kilani, M, et al.
Publicado: (2023)

Automatic subcutaneous defibrillator screening in patients with intracardiac devices: comparative study depending on the point of pacing
por: Cabrera Borrego, E, et al.
Publicado: (2023)

Long term longevity of defibrillator leads: a prospective follow-up over 25 years
por: Davril, C, et al.
Publicado: (2023)

A manual synchronous low energy shock impedance as a predictor of successful defibrillation testing during subcutaneous icd implantation
por: Lopez Perales, C, et al.
Publicado: (2023)

A tertiary centre experience of routine exercise testing as part of subcutaneous ICD vector mapping
por: Hall, P, et al.
Publicado: (2023)

Trends in adoption of extravascular devices compared to conventional devices: real-world data from the Netherlands Heart Registration
por: Breeman, K T N, et al.
Publicado: (2023)

Capsulectomy: a safe and effective way to lower shock impedance in S-ICD replacement procedures
por: Wuerfel, S, et al.
Publicado: (2023)

Beneficial effects of high output His bundle pacing in patients with heart failure, narrow QRS
por: Katsouras, G, et al.
Publicado: (2023)

Do co-morbidities, frailty and functional status identify patients who may not benefit from ICD therapy?
por: Wilson, D G, et al.
Publicado: (2023)

Validation of a transthoracic impendance sensor for screening of sleep apnea in CIED patients: a pooled analysis of AIRLESS and UPGRADE
por: Barbieri, F, et al.
Publicado: (2023)

Subcutaneous ICD therapy results in a similar quality of life compared with transvenous ICD therapy during both short- and long-term follow-up
por: De Veld, J A, et al.
Publicado: (2023)

Single center experience with subcutaneous ICD in combination with previously implanted endocardial or epicardial antibradycardia or cardiac resynchronization devices
por: Som, Z, et al.
Publicado: (2023)

Evolution of surface and endocavitary signals in patients with arrhythmogenic cardiomyopathy at 1 and 5 years
por: Martignani, C, et al.
Publicado: (2023)

A 25-year single-center experience with transvenous and subcutaneous ICD patients under thirty years of age
por: Lewandowski, M, et al.
Publicado: (2023)

ICD patients with first appropriate ICD shock: new treatment concept is associated with better outcome
por: Kleemann, T, et al.
Publicado: (2023)

Evaluation of MADIT II risk stratification score among registry of heart failure patients with primary prevention ICD/CRTD device
por: Rav Acha, M, et al.
Publicado: (2023)

Quality improvements anticipated by guideline adherence to peri-operative ICD deactivation
por: Finnerty, D, et al.
Publicado: (2023)

Long‐term follow‐up of the two‐incision implantation technique for the subcutaneous implantable cardioverter‐defibrillator
por: van der Stuijt, Willeke, et al.
Publicado: (2020)

Facteurs associés à l'infection au SARS-CoV-2 à Tunis après la deuxième vague épidémique
por: Cherif, I., et al.
Publicado: (2022)

Association between implantable cardioverter-defibrillator and survival in patients awaiting heart transplantation: A meta-analysis and systematic review
por: Lin, Andrew Y., et al.
Publicado: (2021)

Implantable cardioverter-defibrillator–related procedures and associated complications in continuous flow left ventricular assist device recipients: A multicenter experience
por: Ravichandran, Ashwin, et al.
Publicado: (2021)

Cardiac defibrillator implantation in patients with syncope and inducible ventricular arrhythmia: insights from the German DEVICE registry
por: Kahle, A K, et al.
Publicado: (2023)

Cardiac defibrillator implantation in patients with syncope and inducible ventricular arrhythmia: insights from the German Device Registry
por: Kahle, Ann-Kathrin, et al.
Publicado: (2023)

Pulsed-field ablation in patients with permanent pacemaker or implantable cardioverter defibrillator: Is it safe?
por: Lennerz, C, et al.
Publicado: (2023)

Real‐world performance of the atrial fibrillation monitor in patients with a subcutaneous ICD
por: Baalman, Sarah W.E., et al.
Publicado: (2020)

2-Phenoxyethanol derivatization in ink dating determination
por: Leal, Teresa Argente, et al.
Publicado: (2021)

RESISTANCE TO GLUCOCORTICOSTEROID THERAPY IN PATIENTS WITH SARS-COV-2 INFECTION WITH ELEVATED MARKERS OF ENDOTOXEMIA
por: Beloglazov, V., et al.
Publicado: (2022)

Appropriate therapy for implantable cardioverter defibrillators used as primary versus secondary prophylaxis
por: Thuraiaiyah, J, et al.
Publicado: (2023)

The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections
por: Castro, L., et al.
Publicado: (2017)

Defibrillation Threshold Testing for Right-sided Device Implants: A Review to Inform Shared Decision-making, in Association with the British Heart Rhythm Society
por: Pope, Michael TB, et al.
Publicado: (2023)

Procedural outcome and risk prediction in young patients undergoing transvenous lead extraction. A GALLERY subgroup analysis
por: Chung, D, et al.
Publicado: (2023)

Safety and efficacy of Laser lead extraction in octo- and nonagenarians. A Subgroup Analysis from the GALLERY registry
por: Pecha, S, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j8tbgaa1kim4pn0h7a234uqjj3